Physician profile
Daniel B Erlanger
NPI 1396709945
$944.51
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $145 · 2021: $40.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $235.34 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $133.00 | 2019 | |
| Pfizer INC. | $98.65 | 2019-2021 | |
| Lilly USA, LLC | $52.63 | 2019 | |
| Astellas Pharma US INC | $51.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $50.52 | 2019-2020 | |
| Daiichi Sankyo INC. | $43.75 | 2019 | |
| Novo Nordisk INC | $40.05 | 2019 | |
| Abbvie INC. | $30.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.18 | 2019-2020 | |
| Sanofi Pasteur INC. | $20.30 | 2019 | |
| Abbott Laboratories | $19.15 | 2019 | |
| Merck Sharp & Dohme LLC | $16.57 | 2019 | |
| Amgen INC. | $15.40 | 2019 | |
| Medtronic USA, INC. | $15.07 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $13.10 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.90 | 2019 | |
| Biogen, INC. | $12.65 | 2020 | |
| Genentech USA, INC. | $12.45 | 2019 | |
| Collegium Pharmaceutical, INC. | $11.67 | 2019 | |
| Amarin Pharma, INC. | $11.60 | 2020 | |
| Philips North America LLC | $11.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Erlanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.